These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 324955)

  • 1. Present status of CMF adjuvant therapy in operable breast cancer.
    Bonadonna G
    Int J Radiat Oncol Biol Phys; 1977; 2(3-4):237-40. PubMed ID: 324955
    [No Abstract]   [Full Text] [Related]  

  • 2. The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?
    Levitt SH; Potish RA
    Cancer Clin Trials; 1981; 4(4):363-9. PubMed ID: 7032731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant combination chemotherapy in primary mammary carcinoma: the CMF program.
    Rossi A; Bonadonna G; Valagussa P; Veronesi U
    Recent Results Cancer Res; 1977; (62):134-42. PubMed ID: 341246
    [No Abstract]   [Full Text] [Related]  

  • 4. The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance.
    Bonadonna G; Rossi A; Valagussa P; Banfi A; Veronesi U
    Cancer; 1977 Jun; 39(6 Suppl):2904-15. PubMed ID: 326384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.
    Mouridsen HT; Palshof T; Engelsman E; Sylvester R
    Eur J Cancer (1965); 1980; Suppl 1():119-23. PubMed ID: 7032921
    [No Abstract]   [Full Text] [Related]  

  • 6. Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes: the Milan Institute experience.
    Bonadonna G; Valagussa P; Rossi A; Tancini G; Brambilla C; Marchini S; Veronesi U
    Recent Results Cancer Res; 1982; 80():149-56. PubMed ID: 7036277
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer.
    Brincker H; Rose C; Rank F; Mouridsen HT; Jakobsen A; Dombernowsky P; Panduro J; Andersen KW
    J Clin Oncol; 1987 Nov; 5(11):1771-8. PubMed ID: 3316514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study.
    Jonat W; Kaufmann M; Sauerbrei W; Blamey R; Cuzick J; Namer M; Fogelman I; de Haes JC; de Matteis A; Stewart A; Eiermann W; Szakolczai I; Palmer M; Schumacher M; Geberth M; Lisboa B;
    J Clin Oncol; 2002 Dec; 20(24):4628-35. PubMed ID: 12488406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant combination chemotherapy with CMF in primary mammary carcinoma.
    Veronesi U; Rossi A; Bonadonna G
    World J Surg; 1977 May; 1(3):337-40. PubMed ID: 883333
    [No Abstract]   [Full Text] [Related]  

  • 10. Multimodal treatment in operable breast cancer: five-year results of the CMF programme.
    Rossi A; Bonadonna G; Valagussa P; Veronesi U
    Br Med J (Clin Res Ed); 1981 May; 282(6274):1427-31. PubMed ID: 6784849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant hormono-chemotherapy in operable breast cancer.
    Wilson R; Hanham IW; Mair G; Drake SR; Derry CD; McKenzie C; Stoll BA; Boesen E; Skeggs DB; Senanayake F
    Lancet; 1978 May; 1(8073):1101. PubMed ID: 77399
    [No Abstract]   [Full Text] [Related]  

  • 12. Surgery and adjuvant chemotherapy in the treatment of operable breast cancer.
    Rossi A; Valagussa P; Bonadonna G
    Prog Clin Biol Res; 1977; 12():391-404. PubMed ID: 335401
    [No Abstract]   [Full Text] [Related]  

  • 13. [Breast neoplasms. Progress by means of adjuvant chemotherapy?].
    Senn HJ
    MMW Munch Med Wochenschr; 1980 Jan; 122(1):10-5. PubMed ID: 6767909
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82.
    Senn HJ; Maibach R; Castiglione M; Jungi WF; Cavalli F; Leyvraz S; Obrecht JP; Schildknecht O; Siegenthaler P
    J Clin Oncol; 1997 Jul; 15(7):2502-9. PubMed ID: 9215818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of Milan.
    Bonadonna G; Rossi A; Tancini G; Bajetta E; Marchini S; Brambilla C; Tesoro Tess JD; Valagussa P; Banfi A; Veronesi U
    Cancer Treat Rep; 1981; 65 Suppl 1():61-5. PubMed ID: 7034930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary results of a continuous study protocol with adjuvant chemotherapy in primary operable breast carcinoma].
    Cavalli F; Jungi F; Alberto P; Martz G; Brunner KW
    Haematol Blood Transfus; 1978; 22():61-6. PubMed ID: 374200
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant chemotherapy with four drugs for stage 2 breast cancer.
    Wheeler TK; Edelstyn GA; Bates TS; Brinkley D; Evans RG; Kitchen G; MacRae KD; Nicol NT; Spittle M; Wheeler TK
    Eur J Cancer (1965); 1980; Suppl 1():161-3. PubMed ID: 7032926
    [No Abstract]   [Full Text] [Related]  

  • 20. [CMF (cyclophosphamide, methotrexate, ftorafur) chemotherapy in advanced breast cancer].
    Gottwald G; Szakolczai I
    Orv Hetil; 1983 Jan; 124(2):79-84. PubMed ID: 6687491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.